Sean Salmon - 16 Dec 2024 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: EVP & President Cardiovascular
Issuer ticker: MDT
Reported as of: 16 Dec 2024
Net transaction value: -$53,200
SEC form: 4
Accepted by SEC: 17 Dec 2024, 17:00:08 UTC
Prior SEC filing: 06 Aug 2024
Next SEC filing: 11 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Thomas L. Osteraas, attorney-in-fact

Key filing fact

Sean Salmon filed Form 4 for Medtronic plc (MDT) on 17 Dec 2024.

Key facts

This page summarizes Sean Salmon's Form 4 filing for Medtronic plc (MDT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Dec 2024, 17:00.

Change

Previous filing in this sequence was filed on 06 Aug 2024.
Current net transaction value: -$53,200.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value: $53,200
Shares: -645
Change %: -0.99%
Price: $82.48
Shares after: 64,722
Date: 16 Dec 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I due to the reporting person's retirement eligibility.

Footnote F2

Includes 257 shares acquired through dividend reinvestment since the last report filed by the reporting person.